Dr. Lal Pathlabs has reported results for fourth quarter (Q4) and year ended March 31, 2023.
The company has reported 9.34% rise in its net profit at Rs 71.40 crore for the quarter under review as compared to Rs 65.30 crore for the same quarter in the previous year. Total income of the company increased by 3.15% at Rs 442.60 crore for Q4FY23 as compared to Rs 429.10 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 8.37% fall in its net profit at Rs 56.90 crore for the quarter under review as compared to Rs 62.10 crore for the same quarter in the previous year. However, total income of the company increased by 1.55% at Rs 505.20 crore for Q4FY23 as compared to Rs 497.50 crore for the corresponding quarter previous year.
For the year ended March 31, 2023, the company has reported 15.32% fall in its net profit at Rs 292.40 crore as compared to Rs 345.30 crore for the previous year. Total income of the company decreased by 6.02% at Rs 1,815.60 crore for year under review as compared to Rs 1,931.90 crore for year ended March 31, 2022.
For the year ended March 31, 2023, on the consolidated basis, the company has reported 31.17% fall in its net profit at Rs 241.10 crore as compared to Rs 350.30 crore for the previous year. Total income of the company decreased by 3.80% at Rs 2,058.60 crore for year under review as compared to Rs 2,139.90 crore for year ended March 31, 2022.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7248.75 |
Max Healthcare Inst | 1166.60 |
Narayana Hrudayalay | 1286.30 |
Aster DM Healthcare | 486.85 |
Global Health | 1098.95 |
View more.. |